New York State Common Retirement Fund’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

New York State Common Retirement Fund’s Portfolio TLIS Stock Details TLIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12	Closed	–	–	3494
2022 Q2	$0	Sell	12 -393	-97%	-$6.21K	﹤0.01%	3556
2022 Q1	$9K	Buy	405 +2	+0.5%	+$69	﹤0.01%	3321
2021 Q4	$24K	Sell	403 -2,071	-84%	-$155K	﹤0.01%	3289
2021 Q3	$232K	Sell	2,474 -87	-3%	-$11.6K	﹤0.01%	2861
2021 Q2	$424K	Sell	2,561 -76	-3%	-$12.9K	﹤0.01%	2692
2021 Q1	$508K	Buy	+2,637	New	+$658K	﹤0.01%	2454

Other funds holding TLIS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York State Common Retirement Fund's TLIS Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q3 2022, closing a stake of 12 shares.

New York State Common Retirement Fund first reported a position in TLIS in Q1 2021 and held it in 6 quarters. The position peaked at $508K in Q1 2021. 29 funds tracked by Wall St. Rank hold TLIS as of Q3 2022.

New York State Common Retirement Fund reported no remaining Talis Biomedical Corporation Common Stock position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 12 Talis Biomedical Corporation Common Stock shares in Q3 2022.
New York State Common Retirement Fund first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 6 quarters.
New York State Common Retirement Fund's Talis Biomedical Corporation Common Stock position peaked at $508K in Q1 2021.
29 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.